Jump Financial’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-108,355	Closed	-$2.89M	–	1826
2025 Q4	$2.89M	Buy	+108,355	New	+$2.59M	0.04%	546
2025 Q1	–	Sell	-154,006	Closed	-$2.83M	–	1540
2024 Q4	$2.83M	Sell	154,006 -12,382	-7%	-$200K	0.06%	415
2024 Q3	$2.56M	Buy	166,388 +124,618	+298%	+$2.08M	0.05%	425
2024 Q2	$679K	Sell	41,770 -107,233	-72%	-$1.73M	0.01%	990
2024 Q1	$2.76M	Buy	149,003 +32,662	+28%	+$809K	0.08%	317
2023 Q4	$3.64M	Buy	116,341 +89,053	+326%	+$2.13M	0.12%	187
2023 Q3	$569K	Sell	27,288 -50,401	-65%	-$1.37M	0.02%	956
2023 Q2	$1.86M	Sell	77,689 -119,221	-61%	-$2.65M	0.07%	419
2023 Q1	$3.71M	Buy	+196,910	New	+$3.75M	0.15%	216
2022 Q4	–	Sell	-13,100	Closed	-$214K	–	1521
2022 Q3	$214K	Sell	13,100 -127,669	-91%	-$2.07M	0.01%	1317
2022 Q2	$1.98M	Buy	140,769 +74,525	+113%	+$1.39M	0.09%	318
2022 Q1	$1.6M	Buy	+66,244	New	+$1.6M	0.07%	344
2021 Q3	–	Sell	-79,060	Closed	-$1.93M	–	1052
2021 Q2	$1.93M	Buy	+79,060	New	+$1.78M	0.19%	114